FDA expected to approve Pfizer booster for children aged 5-11

The FDA is expected to approve Pfizer vaccine booster shots for children aged 5 to 11, with the official announcement slated to come as early as this week. The federal government is also now taking orders for a third round of free COVID-19 test kits.